Evolution of the Diagnosis and Treatment of Primary Hyperparathyroidism
Journal of Clinical Medicine · 06.03.2023 · 12 (5) · 2057
DOI: 10.3390/jcm12052057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 06.03.2023. Verfasst von Enrico Battistella und 6 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine Surgery Unit, Department of Surgery, Veneto Institute of Oncology, IOV-IRCCS, Via Gattamelata 64, 35128 Padua, Italy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health Ricerca Corrente.
Abstract (Originalsprache)
This study aims to present the evolution of our center’s approach to treating primary hyperparathyroidism (PHPT) from diagnosis to intraoperative interventions. We have also evaluated the intraoperative localization benefits of indocyanine green fluorescence angiography. This retrospective single-center study involved 296 patients who underwent parathyroidectomy for PHPT between January 2010 and December 2022. The preoperative diagnostic procedure included neck ultrasonography in all patients, [99mTc]Tc-MIBI scintigraphy in 278 patients, and, in 20 doubtful cases, [18F] fluorocholine positron emission tomography (PET) computed tomography (CT) was performed. Intraoperative PTH was measured in all cases. Indocyanine green has been administered intravenously since 2020 to guide surgical navigation using a fluorescence imaging system. The development of high precision diagnostic tools that can localize an abnormal parathyroid gland in combination with intra-operative PTH assay (ioPTH) enables the surgical treatment of PHPT patients with focused approaches and excellent results that are stackable with bilateral neck exploration (98% of surgical success). Indocyanine green angiography has the potential to assist surgeons in identifying parathyroid glands rapidly and with minimal risk, especially when pre-operative localization has failed. When everything else fails, it is only an experienced surgeon who can resolve the situation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Endocrine Surgery Unit, Department of Surgery, Veneto Institute of Oncology, IOV-IRCCS, Via Gattamelata 64, 35128 Padua, Italy.
- School of Medicine, University of Padua, Via Giustiniani 2, 35128 Padua, Italy.
- Department of Nuclear Medicine, Veneto Institute of Oncology, IOV-IRCCS, Via Gattamelata 64, 35128 Padua, Italy.
- Familial Cancer Unit, Veneto Institute of Oncology, IOV-IRCCS, Via Gattamelata 64, 35128 Padua, Italy.
ORCID-Profile: Enrico Battistella, Sara Watutantrige Fernando
Förderung
- Italian Ministry of Health Ricerca Corrente
Zitieren
APA
Battistella, E., Pomba, L., Toniato, R., Burei, M., Gregianin, M., Watutantrige Fernando, S., & Toniato, A. (2023). Evolution of the Diagnosis and Treatment of Primary Hyperparathyroidism. Journal of Clinical Medicine, 12(5), 2057. https://doi.org/10.3390/jcm12052057
Vancouver
Battistella E, Pomba L, Toniato R, Burei M, Gregianin M, Watutantrige Fernando S, et al. Evolution of the Diagnosis and Treatment of Primary Hyperparathyroidism. Journal of Clinical Medicine. 2023;12(5):2057. doi:10.3390/jcm12052057
BibTeX
@article{Battistella2023,
author = {Battistella, Enrico and Pomba, Luca and Toniato, Riccardo and Burei, Marta and Gregianin, Michele and Watutantrige Fernando, Sara and Toniato, Antonio},
title = {Evolution of the Diagnosis and Treatment of Primary Hyperparathyroidism},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {5},
pages = {2057},
doi = {10.3390/jcm12052057}
}
EUVIMED